Orchid Pharma Limited has informed the Exchange regarding 'Boards comment on fine levied by Exchange'.

Sebi PenaltyRegulatory & Legal View source PDF Explain this filing

ORCHPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.0%Reaction day

₹669.00

prior close

₹655.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-5.4% vs market

Pharmaceuticals peers, median of 147sector+0.5%-5.5% vs sector

On the reaction day the stock moved 5.4 pts less than Nifty Microcap 250 and 5.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.9

10m

-1.3

15m

-2.4

30m

-3.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.0+0.4-5.4+0.5-5.5

Next day

-5.8+0.7-6.5-0.2-5.6

-1.3+0.7-2.1-0.3-1.0

+3.2+0.5+2.7-0.5+3.6

+8.3+1.0+7.3-0.2+8.5

+8.3+1.5+6.8-0.1+8.4

+8.8+2.8+6.0+0.4+8.4

15d

+1.8-0.7+2.5-3.0+4.8

+6.8+3.7+3.1-0.2+7.0

+4.3+3.0+1.4+1.2+3.2

+9.9-1.4+11.3-4.2+14.1

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 147Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Orchid Pharma received a notice from NSE dated March 17, 2025, for non-compliance with Regulation 17(1A) of SEBI (LODR) Regulations, 2015, along with a fine. The company had already paid the fine and informed the exchange on March 31, 2025. The Board of Directors reviewed the matter in its meeting on May 26, 2025, took note of the exchange's communication, and resolved to avoid such non-compliance in the future. The filing is a formal board acknowledgment of the regulatory action and a commitment to compliance going forward.

Likely market impact

This is a routine disclosure confirming that a regulatory fine has been paid and the board has acknowledged the lapse. For shareholders, this signals governance awareness but the financial impact is likely minimal since the fine has already been settled.